参考文献:1. Chen C-K, Leung SSF, Guilbert C et al (2010) Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. PLoS Negl Trop Dis 4:e651 2. Cresnar B, Petric S (2011) Cytochrome P450 enzymes in the fungal kingdom. Biochim Biophys Acta-Proteins Proteomics 1814:29–35 3. Eswar N, Webb B, Marti-Renom MA et al (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci 2:15–32 4. Ghosoph JM, Schmidt LS, Margosan DA et al (2007) Imazalil resistance linked to a unique insertion sequence in the PdCYP51 promoter region of Penicillium digitatum. Postharvest Biol Tec 44:9–18 5. Guardiola-Diaz HM, Foster L-A, Mushrush D et al (2001) Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Biochem Pharmacol 61:1463–1470 6. Ji H, Zhang W, Zhang M et al (2003) Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14α-demethylase of fungi. J Med Chem 46:474–485 7. Lamb DC, Kelly DE, Venkateswarlu K et al (1999) Generation of a complete, soluble, and catalytically active sterol 14 alpha-demethylase-reductase complex. Biochemistry 38:8733–8738 8. Lepesheva GI, Waterman MR (2007) Sterol 14 alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim Biophys Acta Gen Subjects 1770:467–477 9. Lepesheva GI, Waterman MR (2011) Structural basis for conservation in the CYP51 family. BBA-Proteins Proteomics 1814:88–93 10. Lepesheva G, Hargrove T, Kleshchenko Y et al (2008) CYP51: a major drug target in the cytochrome P450 superfamily. Lipids 43:1117–1125 11. Lepesheva GI, Hargrove TY, Anderson S et al (2010a) Structural insights into inhibition of sterol 14α-demethylase in the human pathogen Trypanosoma cruzi. J Biol Chem 285:25582–25590 12. Lepesheva GI, Park HW, Hargrove TY et al (2010b) Crystal structures of Trypanosoma brucei sterol 14 alpha-demethylase and implications for selective treatment of human infections. J Biol Chem 285:1773–1780 13. Lindahl E, Hess B, van der Spoel D (2001) GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Model 7:306–317 14. Morris GM, Goodsell DS, Halliday RS et al (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662 15. Sheng C, Zhang W, Zhang M et al (2004) Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate interactions. J Biomol Struct Dyn 22:91–99 16. Sheng CQ, Miao ZY, Ji HT et al (2009) Three-dimensional model of lanosterol 14-alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding. Antimicrob Agents Chemother 53:3487–3495 17. Strushkevich N, Usanov SA, Park HW (2010) Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol 397:1067–1078 18. Wang W, Wang S, Liu Y et al (2010) Novel conformationally restricted triazole derivatives with potent antifungal activity. Eur J Med Chem 45:6020–6026 19. Zhang QY, Li DL, Wei P et al (2010) Structure-based rational screening of novel hit compounds with structural diversity for cytochrome p450 sterol 14α-demethylase from Penicillium digitatum. J Chem Inf Model 50:317–325 20. Zhao L, Liu DL, Zhang QY, Zhang S et al (2007) Expression and homology modeling of sterol 14-alpha-demethylase from Penicillium digitatum. FEMS Microbiol Lett 277:37–43
作者单位:1. Hubei Key Laboratory of Genetic Regulation and Integrative Biology, College of Life Science, Central China Normal University, No. 152 Luo-Yu Road, Wuhan, 430079 People’s Republic of China2. Institute of Horticulture Qinghai Academy of Agriculture & Forestry, Qinghai University, Xining, 810016 People’s Republic of China3. College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430079 People’s Republic of China
Sterol 14α-demethylase from Penicillium digitatum (PdCYP51) is a prime target of antifungal drugs for citrus disease in plants. To design novel antifungal compounds, a homology model of PdCYP51 was constructed using the recently reported crystal structure of human CYP51 as the template. Molecular docking was performed to investigate the interaction of four commercial fungicides with the modeled enzyme. The side chain of these compounds interplayed with PdCYP51 mainly through hydrophobic and van der Waals interactions. Biochemical spectra analysis of inhibitors combined with PdCYP51 are also compatible with the docking results. This is the first molecular modeling for PdCYP51 based on the eukaryotic crystal structure of CYP51. The structural information and binding site mapping of PdCYP51 for different inhibitors obtained from this study could aid in screening and designing new antifungal compounds targeting this enzyme.